A quick overview of of IPOs in medtech arena. Along with, perception difference amid various healthcare wings including Biopharma, Diagnostics and Medical Devices.
Some of the recent developments at regulatory front which ranges from introduction of novel process and devices to FDA scrutiny to therapeutic areas taking a lead in field of approval.
Image Source: http://www.huffingtonpost.com Medical device OEMs have been on M&A bandwagon for long , either to scale up their market share or to become one stop shop for hospitals. However M&As now […]